Yi F. Luo

State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

A boronate affinity-enhanced and PEGylated cell-imprinted platform for efficient capture of circulating colorectal cancer cells.

A boronate affinity-enhanced and PEGylated cell-imprinted platform for efficient capture of circulating colorectal cancer cells.

Journal: Analytica chimica acta
Published: January 05, 2026

Novel Phosphatase SSU72 Drives Malignant Progression in Colorectal Cancer via PERK Thr982 Dephosphorylation Mediated Endoplasmic Reticulum Stress Inactivation.

Novel Phosphatase SSU72 Drives Malignant Progression in Colorectal Cancer via PERK Thr982 Dephosphorylation Mediated Endoplasmic Reticulum Stress Inactivation.

Journal: International journal of biological sciences
Published: December 06, 2025

Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma.

Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma.

Journal: Liver cancer
Published: August 26, 2025

cPLA2α inhibition potentiates anti-PD-1 immunotherapy in lung adenocarcinoma via remodeling tumor microenvironment.

cPLA2α inhibition potentiates anti-PD-1 immunotherapy in lung adenocarcinoma via remodeling tumor microenvironment.

Journal: Communications biology
Published: July 25, 2025

Tracheobronchial adenoid cystic carcinoma: a two-center retrospective analysis of clinical features and survival outcomes.

Tracheobronchial adenoid cystic carcinoma: a two-center retrospective analysis of clinical features and survival outcomes.

Journal: European journal of medical research
Published: July 08, 2025

Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Journal: Cell death & disease
Published: April 13, 2025

5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma.

5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma.

Journal: EMBO molecular medicine
Published: March 05, 2025

Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy.

Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy.

Journal: Cell reports. Medicine
Published: February 21, 2025

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma.

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma.

Journal: Frontiers in pharmacology
Published: February 15, 2025

DNAJC24 suppresses breast cancer malignancy and serves as a prognostic biomarker.

DNAJC24 suppresses breast cancer malignancy and serves as a prognostic biomarker.

Journal: Cancer cell international
Published: February 07, 2025

PNO1 served as a potential biomarker to promote the stemness and progression of breast cancer via the NF-κB signaling pathway.

PNO1 served as a potential biomarker to promote the stemness and progression of breast cancer via the NF-κB signaling pathway.

Journal: Stem cells (Dayton, Ohio)
Published: November 26, 2024

Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma.

Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma.

Journal: Cell death & disease
Published: November 26, 2024
Showing 1-12 of 51

Last Updated: 09/26/2026